BioLife Solutions, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062W2044
USD
19.08
0.72 (3.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Artivion, Inc.
BioLife Solutions, Inc.
Varex Imaging Corp.
Treace Medical Concepts, Inc.
Silk Road Medical, Inc.
Embecta Corp.
OrthoPediatrics Corp.
The Beauty Health Co.
Atrion Corp.
Cytek Biosciences, Inc.
Nevro Corp.

Why is BioLife Solutions, Inc. ?

1
The company has declared Positive results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 16.84 MM
  • NET SALES(Q) Highest at USD 28.07 MM
  • RAW MATERIAL COST(Y) Fallen by 1.39% (YoY)
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -23.68%, its profits have risen by 6.8%
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Below par performance in long term as well as near term
  • Along with generating -23.68% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to BioLife Solutions, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is BioLife Solutions, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
BioLife Solutions, Inc.
-23.68%
-0.22
51.63%
S&P 500
18.81%
0.98
19.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
19.17%
EBIT Growth (5y)
-242.91%
EBIT to Interest (avg)
-24.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.32
Tax Ratio
1.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.61
EV to EBIT
-42.48
EV to EBITDA
-57.79
EV to Capital Employed
3.00
EV to Sales
8.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.05%
ROE (Latest)
-4.99%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 16.84 MM

NET SALES(Q)

Highest at USD 28.07 MM

RAW MATERIAL COST(Y)

Fallen by 1.39% (YoY

CASH AND EQV(HY)

Highest at USD 160.72 MM

OPERATING PROFIT(Q)

Highest at USD 1.25 MM

PRE-TAX PROFIT(Q)

Highest at USD 0.7 MM

NET PROFIT(Q)

Highest at USD 0.62 MM

-8What is not working for the Company
NET PROFIT(HY)

At USD -15.22 MM has Grown at -677.57%

Here's what is working for BioLife Solutions, Inc.

Operating Cash Flow
Highest at USD 16.84 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 28.07 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Pre-Tax Profit
At USD 0.7 MM has Grown at 114.93%
over average net sales of the previous four periods of USD -4.71 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 0.62 MM has Grown at 113.24%
over average net sales of the previous four periods of USD -4.69 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
At USD 28.07 MM has Grown at 20.12%
over average net sales of the previous four periods of USD 23.37 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 1.25 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD 0.7 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 0.62 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Cash and Eqv
Highest at USD 160.72 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 1.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales